NCT03353831
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03353831
Title Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors AGO Research GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | LTU | FRA | FIN | EST | ESP | DNK | DEU | CHE | BEL | AUT

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field